Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Beam Therapeutics Inc.

Present clinical data on multiple patients for BEAM-101

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
8 Jan 2024
Due
31 Dec 2024
Delivered
December 2024
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Present clinical data on multiple patients in second half of 2024”

What we found

Evidence strength A What the grades mean

The company presented preliminary clinical data for BEAM-101 at the American Society of Hematology Annual Meeting in December 2024, fulfilling the commitment to present data in the second half of 2024.

  • A
    Beam Therapeutics Inc. 10-K filed 2025-02-25 Regulatory filing · published 25 Feb 2025 · retrieved 2 Oct 2026 · kept permanently by the SEC
    “In December 2024, we announced preliminary positive data from our Phase 1/2 clinical trial of BEAM-101, which we refer to as the BEACON trial.” ✓ confirmed on the page
  • A
    Beam Therapeutics Inc. 10-Q filed 2025-05-06 Regulatory filing · published 6 May 2025 · retrieved 2 Oct 2026 · kept permanently by the SEC
    “The presentation contained preliminary data as of October 28, 2024 from seven patients in the trial” ✓ confirmed on the page

Market reaction: the shares moved -9.9% against the S&P 500 over the three sessions around the disclosure (24 Feb 2025 to 27 Feb 2025). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Present
Deliverable
BEAM-101 clinical data
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-BEAM-003259 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.